meglumine has been researched along with Infarct in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Affronti, M; Di Rosa, S; Malta, R; Peralta, S; Renda, M; Rini, GB; Savalli, F; Scardavi, M; Trifiró, G | 1 |
| Bartlett, ST; Chow, CC; Daly, B; Krebs, TL; Wong, JJ | 1 |
2 other study(ies) available for meglumine and Infarct
| Article | Year |
|---|---|
Acute abdominal pain during therapy with glucantim: splenic infarct or excessive splenic enlargement?
Topics: Abdominal Pain; Adolescent; Antiprotozoal Agents; Diagnosis, Differential; Fatal Outcome; Humans; Infarction; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Spleen; Splenomegaly; Treatment Outcome | 1989 |
Vascular complications of pancreatic transplantation: MR evaluation.
Topics: Adult; Chronic Disease; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Graft Occlusion, Vascular; Graft Rejection; Humans; Image Enhancement; Infarction; Kidney Transplantation; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreas; Pancreas Transplantation; Pentetic Acid; Regional Blood Flow; Thrombosis; Vascular Diseases; Vascular Patency | 1995 |